EMA News

EMA’s human medicines committee (CHMP) has recommended the suspension of the marketing authorisations of generic medicines tested by Panexcell Clinical... Array

Content Original Link:

https://www.ema.europa.eu/en/news/panexcell-clinical-laboratories-suspension-medicines-over-flawed-studies